425 related articles for article (PubMed ID: 11198926)
21. Growth arrest and induction of apoptosis in breast cancer cells by antisense depletion of protein kinase A-RI alpha subunit: p53-independent mechanism of action.
Srivastava RK; Srivastava AR; Seth P; Agrawal S; Cho-Chung YS
Mol Cell Biochem; 1999 May; 195(1-2):25-36. PubMed ID: 10395066
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of pancreatic cancer cell growth and induction of apoptosis with novel therapies directed against protein kinase A.
Farrow B; Rychahou P; Murillo C; O'connor KL; Iwamura T; Evers BM
Surgery; 2003 Aug; 134(2):197-205. PubMed ID: 12947318
[TBL] [Abstract][Full Text] [Related]
23. A high-efficacy antisense RIalpha poly-DNP 21-nt RNA.
Shen L; Chen X; Wang JH
Antisense Nucleic Acid Drug Dev; 2003 Feb; 13(1):67-74. PubMed ID: 12691537
[TBL] [Abstract][Full Text] [Related]
24. Synergistic inhibition of human cancer cell growth by cytotoxic drugs and mixed backbone antisense oligonucleotide targeting protein kinase A.
Tortora G; Caputo R; Damiano V; Bianco R; Pepe S; Bianco AR; Jiang Z; Agrawal S; Ciardiello F
Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12586-91. PubMed ID: 9356493
[TBL] [Abstract][Full Text] [Related]
25. Cyclic adenosine 3':5'-monophosphate-dependent protein kinase on the external surface of LS-174T human colon carcinoma cells.
Kondrashin A; Nesterova M; Cho-Chung YS
Biochemistry; 1999 Jan; 38(1):172-9. PubMed ID: 9890895
[TBL] [Abstract][Full Text] [Related]
26. 8-Chloroadenosine mediates 8-chloro-cyclic AMP-induced down-regulation of cyclic AMP-dependent protein kinase in normal and neoplastic mouse lung epithelial cells by a cyclic AMP-independent mechanism.
Lange-Carter CA; Vuillequez JJ; Malkinson AM
Cancer Res; 1993 Jan; 53(2):393-400. PubMed ID: 8380255
[TBL] [Abstract][Full Text] [Related]
27. Flow-cytometric detection of the RI alpha subunit of type I cAMP-dependent protein kinase in human cells.
Pepe S; Ruggiero A; Tortora G; Ciardiello F; Garbi C; Yokozaki H; Cho-Chung YS; Clair T; Skalhegg BS; Bianco AR
Cytometry; 1994 Jan; 15(1):73-9. PubMed ID: 8162827
[TBL] [Abstract][Full Text] [Related]
28. Increased expression of the RIalpha subunit of the cAMP-dependent protein kinase A is associated with advanced stage ovarian cancer.
McDaid HM; Cairns MT; Atkinson RJ; McAleer S; Harkin DP; Gilmore P; Johnston PG
Br J Cancer; 1999 Feb; 79(5-6):933-9. PubMed ID: 10070893
[TBL] [Abstract][Full Text] [Related]
29. Perturbation of the expression of the catalytic subunit C alpha of cyclic AMP-dependent protein kinase inhibits TCR-triggered secretion of IL-2 by T helper hybridoma cells.
Sugiyama H; Chen P; Hunter MG; Sitkovsky MV
J Immunol; 1997 Jan; 158(1):171-9. PubMed ID: 8977188
[TBL] [Abstract][Full Text] [Related]
30. The differential response of protein kinase A to cyclic AMP in discrete brain areas correlates with the abundance of regulatory subunit II.
Ventra C; Porcellini A; Feliciello A; Gallo A; Paolillo M; Mele E; Avvedimento VE; Schettini G
J Neurochem; 1996 Apr; 66(4):1752-61. PubMed ID: 8627334
[TBL] [Abstract][Full Text] [Related]
31. Selective modulation of protein kinase A I and II reveals distinct roles in thyroid cell gene expression and growth.
Calebiro D; de Filippis T; Lucchi S; Martinez F; Porazzi P; Trivellato R; Locati M; Beck-Peccoz P; Persani L
Mol Endocrinol; 2006 Dec; 20(12):3196-211. PubMed ID: 16887886
[TBL] [Abstract][Full Text] [Related]
32. Cyclic AMP-dependent protein kinase (PKA) gene expression is developmentally regulated in fetal lung.
Acarregui MJ; Brown JJ; Penisten ST
Biochim Biophys Acta; 1998 Apr; 1402(3):303-12. PubMed ID: 9606989
[TBL] [Abstract][Full Text] [Related]
33. Modulation of regulatory and catalytic subunit levels of cAMP-dependent protein kinase A in anterior pituitary cells in response to direct activation of protein kinases A and C or after GnRH stimulation.
Garrel G; Delahaye R; Hemmings BA; Counis R
Neuroendocrinology; 1995 Nov; 62(5):514-22. PubMed ID: 8559283
[TBL] [Abstract][Full Text] [Related]
34. Antisense oligonucleotide targeted to RIalpha subunit of cAMP-dependent protein kinase (GEM231) enhances therapeutic effectiveness of cancer chemotherapeutic agent irinotecan in nude mice bearing human cancer xenografts: in vivo synergistic activity, pharmacokinetics and host toxicity.
Wang H; Hang J; Shi Z; Li M; Yu D; Kandimalla ER; Agrawal S; Zhang R
Int J Oncol; 2002 Jul; 21(1):73-80. PubMed ID: 12063552
[TBL] [Abstract][Full Text] [Related]
35. Antisense DNA toward type I protein kinase A produces sustained inhibition of tumor growth.
Cho-Chung YS
Proc Assoc Am Physicians; 1997 Jan; 109(1):23-32. PubMed ID: 9010913
[TBL] [Abstract][Full Text] [Related]
36. Extracellular catalytic subunit activity of the cAMP-dependent protein kinase in prostate cancer.
Cvijic ME; Kita T; Shih W; DiPaola RS; Chin KV
Clin Cancer Res; 2000 Jun; 6(6):2309-17. PubMed ID: 10873081
[TBL] [Abstract][Full Text] [Related]
37. Cyclic AMP-dependent protein kinase (cAK) in human B cells: co-localization of type I cAK (RI alpha 2 C2) with the antigen receptor during anti-immunoglobulin-induced B cell activation.
Levy FO; Rasmussen AM; Taskén K; Skålhegg BS; Huitfeldt HS; Funderud S; Smeland EB; Hansson V
Eur J Immunol; 1996 Jun; 26(6):1290-6. PubMed ID: 8647207
[TBL] [Abstract][Full Text] [Related]
38. Protein kinase A-directed antisense restrains cancer growth: sequence-specific inhibition of gene expression.
Cho-Chung YS
Antisense Nucleic Acid Drug Dev; 1996; 6(3):237-44. PubMed ID: 8915509
[TBL] [Abstract][Full Text] [Related]
39. Active site coupling in PDE:PKA complexes promotes resetting of mammalian cAMP signaling.
Krishnamurthy S; Moorthy BS; Xin Xiang L; Xin Shan L; Bharatham K; Tulsian NK; Mihalek I; Anand GS
Biophys J; 2014 Sep; 107(6):1426-40. PubMed ID: 25229150
[TBL] [Abstract][Full Text] [Related]
40. Tumor reversion: protein kinase A isozyme switching.
Cho-Chung YS; Nesterova MV
Ann N Y Acad Sci; 2005 Nov; 1058():76-86. PubMed ID: 16394127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
